Normal pulmonary vascular resistance (PVR) at rest in a healthy adult falls between roughly 0.5 and 2.0 Wood units (WU), with the upper limit of normal set at about 2 WU according to current international guidelines. That ceiling dropped in 2022 from the previously used threshold of 3 WU, a change that redrew the diagnostic boundary for pulmonary hypertension and caught a new population of patients whose readings would previously have been considered borderline.
What PVR Actually Tells You
PVR quantifies how hard the right side of your heart has to work to push blood through the lungs. The lungs are normally a low-pressure system: unlike the systemic circulation, which carries blood at relatively high pressures to every organ, the pulmonary circuit runs at pressures several times lower. That design keeps the thin-walled capillaries surrounding the air sacs from leaking fluid. PVR is calculated from the pressure drop across the pulmonary circulation divided by how much blood flows through it per minute. A low number means blood moves easily; a high number means the vessels are narrower, stiffer, or obstructed.
The unit of measurement is named after Paul Wood, a mid-twentieth-century cardiologist who pioneered hemodynamic assessment of the pulmonary circulation. One Wood unit equals one millimeter of mercury per liter per minute (mmHg/L/min). Several factors influence PVR under normal conditions, including the physical structure of the blood vessels, gravity, the mechanical effects of breathing, and signals from the nervous system and circulating hormones. Low oxygen levels cause the pulmonary vessels to constrict, a reflex called hypoxic pulmonary vasoconstriction, which redirects blood toward better-ventilated parts of the lung.
Why the Threshold Dropped in 2022
For decades, pulmonary hypertension was defined by a mean pulmonary artery pressure (mPAP) of 25 mmHg or higher. PVR entered and exited the formal diagnostic criteria over the years, with a threshold of greater than 3 WU adopted in 2013 to help distinguish true pre-capillary pulmonary hypertension from conditions where pressures are elevated simply because the heart pumps more blood than usual.
The 2022 ESC/ERS guidelines changed both numbers. The mPAP threshold dropped from 25 to 20 mmHg, and PVR of 2 WU or above became a mandatory criterion for pre-capillary pulmonary hypertension.1PubMed Central. Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality The guideline authors noted that PVR depends on body surface area and age, with older healthy individuals having somewhat higher values, but that available data placed the upper limit of normal and the lowest prognostically meaningful threshold at around 2 WU.2European Heart Journal. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension – Section: 3. Definitions
The case for lowering the bar came in part from outcome data. A large retrospective study found that the risk of death began climbing at a PVR of about 2.2 WU compared with 1.0 WU. Among patients who had mildly elevated pressures and normal wedge pressures, those with PVR at or above 2.2 WU had roughly 70 percent higher mortality than those below that level, and a modestly higher rate of heart failure hospitalization as well.3PubMed Central. The Association Between Pulmonary Vascular Resistance and Clinical Outcomes in Patients with Pulmonary Hypertension: A Retrospective Cohort Study The validation cohort in that study confirmed the pattern, with an adjusted mortality hazard ratio of 1.81 for PVR at or above 2.2 WU.4The Lancet Respiratory Medicine. Association of pulmonary vascular resistance with clinical outcomes in patients with pulmonary hypertension: a retrospective cohort study In other words, readings that the old framework would have labeled “normal” were already carrying meaningful prognostic weight.
How PVR Is Measured
The gold standard is right heart catheterization. A thin catheter enters through a large vein, typically in the neck or groin, and is threaded through the right side of the heart into the pulmonary artery. Once in place, it measures right atrial pressure, right ventricular pressure, pulmonary artery pressure, and the wedge pressure that reflects left atrial filling. Cardiac output is measured simultaneously, and PVR is calculated from those numbers.5PubMed Central. Right heart catheterization in clinical practice: a review of basic physiology and important issues relevant to interpretation The procedure is invasive but generally safe in experienced centers, and it remains the only way to get the precise hemodynamic measurements the diagnosis formally requires.
Because catheterization is not something you do casually, there has been sustained interest in estimating PVR noninvasively. Echocardiography is the most widely available option. Several models use Doppler measurements of blood flow velocity in the right ventricular outflow tract and estimated systolic pressures to approximate PVR. These echo-based estimates correlate reasonably well with catheterization values and are accurate to within about 2 WU in over three-quarters of patients, though the precision varies and the agreement intervals remain wide.6PubMed Central. Echocardiographic estimation of pulmonary vascular resistance in advanced lung disease A newer Doppler-based method analyzing right ventricular outflow tract notching time and ejection time has shown strong performance across a range of PVR values from about 2 to 14 WU.7PubMed Central. Noninvasive Estimation of Pulmonary Vascular Resistance Using Right Ventricular Outflow Doppler Analysis
Cardiac magnetic resonance (CMR) imaging offers another noninvasive route. A meta-analysis pooling studies of CMR-based PVR estimation in patients with pulmonary hypertension found a pooled correlation of 0.85 with catheterization-derived PVR and no statistically significant systematic bias.8PubMed. The feasibility in estimating pulmonary vascular resistance by cardiovascular magnetic resonance in pulmonary hypertension: A systematic review and meta-analysis Individual CMR models have combined metrics like pulmonary artery flow velocity, right ventricular ejection fraction, and vessel area change to achieve high accuracy. One model correctly classified 90 percent of patients as having normal or elevated PVR.9European Heart Journal. Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance More advanced 4D flow MRI techniques, which map blood velocity in three dimensions over time, have produced even tighter correlations with catheterization in smaller studies.10PubMed Central. 4D magnetic resonance flow imaging for estimating pulmonary vascular resistance in pulmonary hypertension All of these noninvasive approaches are useful for screening and follow-up, but catheterization remains necessary to confirm a diagnosis and guide treatment decisions.
Age, Body Size, and Children
PVR is not a fixed number across the lifespan. The 2022 guidelines explicitly acknowledge that older adults tend to have higher values, even when perfectly healthy, because the pulmonary vessels gradually stiffen with age. That stiffening reduces the ability of the vessels to stretch and accommodate increased blood flow, a property researchers describe as vascular distensibility. Studies of distensibility in healthy adults have found that it declines both with aging and with chronic hypoxia, in situations where some degree of vascular remodeling or wall stiffening is expected.11PubMed. Distensibility of the normal human lung circulation during exercise
In children, the picture has a wrinkle. Pulmonary artery pressure drops rapidly after birth and reaches adult levels by around two to three months of age. Because small children have low absolute blood flow through the lungs, their raw PVR number is actually higher than an adult’s. As the child grows and pulmonary blood flow increases with body size, PVR falls. Clinicians working with pediatric patients therefore index PVR to body surface area, creating a value (PVRi) that stays relatively stable throughout childhood and allows meaningful comparison across ages and body sizes. In adults the indexing convention is less universally applied, which can introduce confusion when comparing values across studies or centers.
That confusion extends to the published literature itself. A review of all articles in PubMed using the term “PVRI” found 218 sources that defined units, with 33 unique unit variants in circulation. Just under half of those sources used what the authors defined as the correct units; the slight majority reported PVRI with incorrect units.12PubMed Central. Pulmonary vascular resistance index: Getting the units right and why it matters For anyone reading hemodynamic data across multiple papers or clinical reports, the takeaway is to check the units carefully before comparing numbers.
How Exercise Changes PVR
During physical exertion, cardiac output can double or triple, yet pulmonary artery pressure rises only modestly in a healthy person. The reason is that the lung vessels recruit unused capillaries and dilate existing ones, absorbing the extra flow without a proportional spike in pressure. A systematic review of exercise hemodynamics in healthy subjects found that during moderate exercise in people aged 50 or younger, cardiac output rose by about 85 percent while PVR actually fell by roughly 12 percent.13PubMed. Pulmonary vascular resistances during exercise in normal subjects: a systematic review Total pulmonary resistance, a slightly broader measure that includes left atrial pressure effects, dropped by 25 percent over the same period.
This exercise-induced drop in PVR is clinically relevant because when it fails to happen, it can be an early sign of pulmonary vascular disease. Some patients have normal resting hemodynamics but an abnormal pressure response to exercise, suggesting their vessels lack the reserve capacity to accommodate increased flow. Exercise hemodynamic testing is not yet part of routine diagnostic criteria for pulmonary hypertension, but it is an active area of research and is already used in some specialized centers to unmask early disease.
Altitude and Chronic Hypoxia
Living at high altitude means breathing air with less oxygen, and the lungs respond by constricting their blood vessels. In the short term, this is the same hypoxic vasoconstriction reflex that optimizes gas exchange in healthy lungs. Over months and years, however, chronic hypoxia drives structural remodeling of the pulmonary vessel walls, thickening them and raising PVR on a more permanent basis.14PubMed Central. Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
A comparative study found that long-term high-altitude residents had an average PVR of about 2.5 WU, compared with roughly 1.6 WU in lowland controls.15European Journal of Cardiovascular Medicine. Impact of Long-term High-Altitude Exposure on Pulmonary Vascular Physiology and Systemic Haemodynamics: A Comparative Study A systematic review and meta-analysis pooling data from healthy high-altitude residents arrived at a primary PVR estimate of 2.4 WU, with a confidence interval of 2.0 to 2.8. After excluding studies at higher risk of bias, the estimate dropped to 2.2 WU, right at the sea-level upper limit of normal.16PubMed. The Association Between Chronic High-Altitude Exposure and Increased Pulmonary Vascular Resistance in Healthy High-Altitude Residents: A Systematic Review and Meta-Analysis
This puts clinicians in an awkward position. Applying a sea-level threshold of 2 WU to populations living above 3,000 meters could pathologize a physiological adaptation rather than identify genuine disease. The current guidelines do not formally adjust PVR thresholds for altitude, which means clinicians in high-altitude regions need to interpret hemodynamic results with extra context. A PVR of 2.5 in a lifelong resident of La Paz means something different from the same number in a patient from London.
What Happens When PVR Stays Elevated
Persistently elevated PVR is the hallmark of pulmonary vascular disease. As resistance climbs, the right ventricle has to generate more and more pressure to push blood through the lungs. Initially the ventricle compensates by thickening its walls, but eventually it dilates and fails. Right heart failure is the leading cause of death in pulmonary arterial hypertension.
Different diseases raise PVR through different mechanisms. In pulmonary arterial hypertension (Group 1), the small arteries in the lungs narrow and remodel. In chronic thromboembolic pulmonary hypertension (CTEPH), organized blood clots physically obstruct the larger pulmonary arteries. CTEPH is one of the few forms of pulmonary hypertension that can be surgically cured. Pulmonary endarterectomy, the procedure that removes the clot material from vessel walls, can dramatically reduce PVR. One large series reported post-operative PVR dropping from about 860 to roughly 295 dyne·s·cm⁻⁵, with corresponding drops in mean pulmonary artery pressure and improvements in cardiac output.17European Respiratory Review. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension – Section: Effectiveness of PEA and survival rates Other surgical series have shown similar reductions, with PVR falling from the mid-700s to around 300 dyne·s·cm⁻⁵ after the procedure.18PLoS ONE. Factors predicting outcome after pulmonary endarterectomy
Preoperative PVR matters for surgical risk too. In one study of patients undergoing pulmonary endarterectomy, preoperative PVR was the only independent predictor of in-hospital death. The cutoff that best distinguished survivors from non-survivors was a preoperative PVR of about 1,052 dyne·s·cm⁻⁵, which is roughly 13 WU.19The Journal of Thoracic and Cardiovascular Surgery. Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension The higher the PVR going in, the more precarious the surgery.
Vasoreactivity Testing and Treatment Response
When a patient is newly diagnosed with pulmonary arterial hypertension, one of the first things clinicians want to know is whether the vessels can still relax. A vasoreactivity test involves giving a short-acting pulmonary vasodilator during right heart catheterization and seeing how much PVR and pressure drop. A positive response suggests the patient may respond to calcium channel blockers, a relatively simple long-term treatment option compared with the more complex drug regimens used in non-responsive patients.
Inhaled nitric oxide is the most widely used agent for this test. When breathed in, nitric oxide relaxes the smooth muscle in pulmonary vessel walls by activating a signaling pathway that leads to vessel dilation. Because it is delivered directly to the lungs and broken down almost immediately in the blood, it acts selectively on pulmonary vessels without dropping systemic blood pressure.20PubMed Central. Inhaled pulmonary vasodilators: a narrative review – Section: Biochemistry and physiological actions A study of 80 patients with pulmonary arterial hypertension found that those whose PVR fell by 30 percent or more during inhaled nitric oxide testing had roughly half the mortality risk over a median follow-up of about two and a half years, compared with patients whose vessels did not respond as strongly.21PubMed Central. Vasoreactivity to inhaled nitric oxide with oxygen predicts long-term survival in pulmonary arterial hypertension PVR is not just a diagnostic measurement in this context; the degree to which it can be driven down acutely helps predict how a patient will fare over time.
High-Altitude Adaptation Across Species
Humans are not the only mammals who have had to cope with thin mountain air. Comparing how different species respond to chronic hypoxia reveals a wide range of pulmonary vascular behavior, and some animals have essentially solved the problem that pulmonary hypertension poses. Cattle and pigs are “hyper-responders,” developing marked pulmonary hypertension at altitude, while sheep and dogs are relative hypo-responders. Species native to high elevations, like yaks and llamas, show attenuated pulmonary pressure responses with minimal vascular wall thickening.22PubMed. Role of vascular smooth muscle in the development of high altitude pulmonary hypertension: an interspecies evaluation
The yak provides a striking example. Researchers studying Ladakhi yaks at about 4,500 meters found that their pulmonary artery pressure was not significantly different from yaks bred at low altitude, meaning the usual hypoxic vasoconstriction reflex had been largely bred out of the species through genetic adaptation. Indigenous Himalayan cattle at the same altitude had significantly higher pulmonary pressures and resistance. Cross-breeds between yaks and cattle showed a split: the first-generation cross (dzo) had hemodynamics resembling the yak, while second-generation crosses were a coin flip, with half resembling the yak pattern and half the cow pattern. The researchers concluded the genetic dampening of hypoxic vasoconstriction appeared to follow a dominant inheritance pattern.23PubMed Central. Pulmonary haemodynamics of the yak, cattle, and cross breeds at high altitude
Similar patterns appear in human populations. Tibetan and Andean highlanders, whose ancestors have lived at extreme altitude for thousands of years, tend to have blunted pulmonary vascular responses to hypoxia compared with recent migrants to the same elevations. The underlying genetics are an active research area, but the parallel with yaks and llamas suggests that natural selection can, given enough generations, substantially reshape the pulmonary circulation’s response to low oxygen, effectively redefining what counts as a “normal” PVR for that population.